The global Proton Pump Inhibitors market was valued at US$ 12190 million in 2023 and is anticipated to reach US$ 9680.8 million by 2030, witnessing a CAGR of -3.2% during the forecast period 2024-2030.

Proton Pump Inhibitors Market

Proton-pump inhibitors (PPIs) are a group of medications whose main action is a pronounced and long-lasting reduction of stomach acid production.

Proton pump inhibitors (PPIs) reduce the production of acid by blocking the enzyme in the wall of the stomach that produces acid. Acid is necessary for the formation of most ulcers in the esophagus, stomach, and duodenum, and the reduction of acid with PPIs prevents ulcers and allows any ulcers that exist in the esophagus, stomach, and duodenum to heal.

PPIs are among the most widely sold medications in the world. The class of proton-pump inhibitor medications is on the World Health Organization's List of Essential Medicines.

Medically used proton pump inhibitors: Omeprazole, Lansoprazole, Dexlansoprazole, Esomeprazole, Pantoprazole, Rabeprazole.

Global Proton Pump Inhibitors key players include AstraZeneca, Takeda, etc. Global top two manufacturers hold a share over 15%.

North America is the largest market, with a share about 30%, followed by Asia-Pacific, and Europe, having a share about 50 percent.

In terms of product, Esomeprazole is the largest segment, with a share about 30%. And in terms of application, the largest application is Hospital Pharmacy, followed by Retail Pharmacy, etc.

This report aims to provide a comprehensive presentation of the global market for Proton Pump Inhibitors, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Proton Pump Inhibitors.

Report Scope

The Proton Pump Inhibitors market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Proton Pump Inhibitors market comprehensively. Regional market sizes, concerning products by Type, by Distribution Channel, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Proton Pump Inhibitors manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Distribution Channel, and by regions.

Market Segmentation

Scope of Proton Pump Inhibitors Market Report

Report Metric	Details
Report Name	Proton Pump Inhibitors Market
Accounted market size in 2023	US$ 12190 million
Forecasted market size in 2030	US$ 9680.8 million
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Dexlansoprazole Esomeprazole Lansoprazole Omeprazole Pantoprazole Rabeprazole
Segment by Distribution Channel	Hospital Pharmacy Retail Pharmacy Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Takeda, Pfizer, AstraZeneca, Bayer, Sun Pharma, Teva, Eisai Co., Mylan, AOSAIKANG Pharma, Luoxin Pharma, LIVZON, Eastchina Pharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Distribution Channel, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Proton Pump Inhibitors manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Proton Pump Inhibitors in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Distribution Channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

What is the Proton Pump Inhibitors Market size in 2030?

Ans: The Proton Pump Inhibitors Market size in 2030 will be US$ 9680.8 million.

What is the market share of major companies in Proton Pump Inhibitors Market?

Ans: Global top two manufacturers hold a share over 15%.

What is the Proton Pump Inhibitors Market share by type?

Ans: In terms of product, Esomeprazole is the largest segment, with a share about 30%.

Who are the main players in the Proton Pump Inhibitors Market report?

Ans: The main players in the Proton Pump Inhibitors Market are Takeda, Pfizer, AstraZeneca, Bayer, Sun Pharma, Teva, Eisai Co., Mylan, AOSAIKANG Pharma, Luoxin Pharma, LIVZON, Eastchina Pharma

What are the Type segmentation covered in the Proton Pump Inhibitors Market report?

Ans: The Types covered in the Proton Pump Inhibitors Market report are Dexlansoprazole, Esomeprazole, Lansoprazole, Omeprazole, Pantoprazole, Rabeprazole

1 Proton Pump Inhibitors Market Overview

1.1 Product Overview and Scope of Proton Pump Inhibitors

1.2 Proton Pump Inhibitors Segment by Type

1.2.1 Global Proton Pump Inhibitors Market Value Comparison by Type (2024-2030)

1.2.2 Dexlansoprazole

1.2.3 Esomeprazole

1.2.4 Lansoprazole

1.2.5 Omeprazole

1.2.6 Pantoprazole

1.2.7 Rabeprazole

1.3 Proton Pump Inhibitors Segment by Distribution Channel

1.3.1 Global Proton Pump Inhibitors Market Value by Distribution Channel: (2024-2030)

1.3.2 Hospital Pharmacy

1.3.3 Retail Pharmacy

1.3.4 Others

1.4 Global Proton Pump Inhibitors Market Size Estimates and Forecasts

1.4.1 Global Proton Pump Inhibitors Revenue 2019-2030

1.4.2 Global Proton Pump Inhibitors Sales 2019-2030

1.4.3 Global Proton Pump Inhibitors Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Proton Pump Inhibitors Market Competition by Manufacturers

2.1 Global Proton Pump Inhibitors Sales Market Share by Manufacturers (2019-2024)

2.2 Global Proton Pump Inhibitors Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Proton Pump Inhibitors Average Price by Manufacturers (2019-2024)

2.4 Global Proton Pump Inhibitors Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Proton Pump Inhibitors, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Proton Pump Inhibitors, Product Type & Application

2.7 Proton Pump Inhibitors Market Competitive Situation and Trends

2.7.1 Proton Pump Inhibitors Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Proton Pump Inhibitors Players Market Share by Revenue

2.7.3 Global Proton Pump Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Proton Pump Inhibitors Retrospective Market Scenario by Region

3.1 Global Proton Pump Inhibitors Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Proton Pump Inhibitors Global Proton Pump Inhibitors Sales by Region: 2019-2030

3.2.1 Global Proton Pump Inhibitors Sales by Region: 2019-2024

3.2.2 Global Proton Pump Inhibitors Sales by Region: 2025-2030

3.3 Global Proton Pump Inhibitors Global Proton Pump Inhibitors Revenue by Region: 2019-2030

3.3.1 Global Proton Pump Inhibitors Revenue by Region: 2019-2024

3.3.2 Global Proton Pump Inhibitors Revenue by Region: 2025-2030

3.4 North America Proton Pump Inhibitors Market Facts & Figures by Country

3.4.1 North America Proton Pump Inhibitors Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Proton Pump Inhibitors Sales by Country (2019-2030)

3.4.3 North America Proton Pump Inhibitors Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe Proton Pump Inhibitors Market Facts & Figures by Country

3.5.1 Europe Proton Pump Inhibitors Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Proton Pump Inhibitors Sales by Country (2019-2030)

3.5.3 Europe Proton Pump Inhibitors Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Proton Pump Inhibitors Market Facts & Figures by Country

3.6.1 Asia Pacific Proton Pump Inhibitors Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Proton Pump Inhibitors Sales by Country (2019-2030)

3.6.3 Asia Pacific Proton Pump Inhibitors Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Proton Pump Inhibitors Market Facts & Figures by Country

3.7.1 Latin America Proton Pump Inhibitors Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Proton Pump Inhibitors Sales by Country (2019-2030)

3.7.3 Latin America Proton Pump Inhibitors Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Proton Pump Inhibitors Market Facts & Figures by Country

3.8.1 Middle East and Africa Proton Pump Inhibitors Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Proton Pump Inhibitors Sales by Country (2019-2030)

3.8.3 Middle East and Africa Proton Pump Inhibitors Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Proton Pump Inhibitors Sales by Type (2019-2030)

4.1.1 Global Proton Pump Inhibitors Sales by Type (2019-2024)

4.1.2 Global Proton Pump Inhibitors Sales by Type (2025-2030)

4.1.3 Global Proton Pump Inhibitors Sales Market Share by Type (2019-2030)

4.2 Global Proton Pump Inhibitors Revenue by Type (2019-2030)

4.2.1 Global Proton Pump Inhibitors Revenue by Type (2019-2024)

4.2.2 Global Proton Pump Inhibitors Revenue by Type (2025-2030)

4.2.3 Global Proton Pump Inhibitors Revenue Market Share by Type (2019-2030)

4.3 Global Proton Pump Inhibitors Price by Type (2019-2030)

5 Segment by Distribution Channel

5.1 Global Proton Pump Inhibitors Sales by Distribution Channel (2019-2030)

5.1.1 Global Proton Pump Inhibitors Sales by Distribution Channel (2019-2024)

5.1.2 Global Proton Pump Inhibitors Sales by Distribution Channel (2025-2030)

5.1.3 Global Proton Pump Inhibitors Sales Market Share by Distribution Channel (2019-2030)

5.2 Global Proton Pump Inhibitors Revenue by Distribution Channel (2019-2030)

5.2.1 Global Proton Pump Inhibitors Revenue by Distribution Channel (2019-2024)

5.2.2 Global Proton Pump Inhibitors Revenue by Distribution Channel (2025-2030)

5.2.3 Global Proton Pump Inhibitors Revenue Market Share by Distribution Channel (2019-2030)

5.3 Global Proton Pump Inhibitors Price by Distribution Channel (2019-2030)

6 Key Companies Profiled

6.1 Takeda

6.1.1 Takeda Corporation Information

6.1.2 Takeda Description and Business Overview

6.1.3 Takeda Proton Pump Inhibitors Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Takeda Proton Pump Inhibitors Product Portfolio

6.1.5 Takeda Recent Developments/Updates

6.2 Pfizer

6.2.1 Pfizer Corporation Information

6.2.2 Pfizer Description and Business Overview

6.2.3 Pfizer Proton Pump Inhibitors Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Pfizer Proton Pump Inhibitors Product Portfolio

6.2.5 Pfizer Recent Developments/Updates

6.3 AstraZeneca

6.3.1 AstraZeneca Corporation Information

6.3.2 AstraZeneca Description and Business Overview

6.3.3 AstraZeneca Proton Pump Inhibitors Sales, Revenue and Gross Margin (2019-2024)

6.3.4 AstraZeneca Proton Pump Inhibitors Product Portfolio

6.3.5 AstraZeneca Recent Developments/Updates

6.4 Bayer

6.4.1 Bayer Corporation Information

6.4.2 Bayer Description and Business Overview

6.4.3 Bayer Proton Pump Inhibitors Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Bayer Proton Pump Inhibitors Product Portfolio

6.4.5 Bayer Recent Developments/Updates

6.5 Sun Pharma

6.5.1 Sun Pharma Corporation Information

6.5.2 Sun Pharma Description and Business Overview

6.5.3 Sun Pharma Proton Pump Inhibitors Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Sun Pharma Proton Pump Inhibitors Product Portfolio

6.5.5 Sun Pharma Recent Developments/Updates

6.6 Teva

6.6.1 Teva Corporation Information

6.6.2 Teva Description and Business Overview

6.6.3 Teva Proton Pump Inhibitors Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Teva Proton Pump Inhibitors Product Portfolio

6.6.5 Teva Recent Developments/Updates

6.7 Eisai Co.

6.6.1 Eisai Co. Corporation Information

6.6.2 Eisai Co. Description and Business Overview

6.6.3 Eisai Co. Proton Pump Inhibitors Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Eisai Co. Proton Pump Inhibitors Product Portfolio

6.7.5 Eisai Co. Recent Developments/Updates

6.8 Mylan

6.8.1 Mylan Corporation Information

6.8.2 Mylan Description and Business Overview

6.8.3 Mylan Proton Pump Inhibitors Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Mylan Proton Pump Inhibitors Product Portfolio

6.8.5 Mylan Recent Developments/Updates

6.9 AOSAIKANG Pharma

6.9.1 AOSAIKANG Pharma Corporation Information

6.9.2 AOSAIKANG Pharma Description and Business Overview

6.9.3 AOSAIKANG Pharma Proton Pump Inhibitors Sales, Revenue and Gross Margin (2019-2024)

6.9.4 AOSAIKANG Pharma Proton Pump Inhibitors Product Portfolio

6.9.5 AOSAIKANG Pharma Recent Developments/Updates

6.10 Luoxin Pharma

6.10.1 Luoxin Pharma Corporation Information

6.10.2 Luoxin Pharma Description and Business Overview

6.10.3 Luoxin Pharma Proton Pump Inhibitors Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Luoxin Pharma Proton Pump Inhibitors Product Portfolio

6.10.5 Luoxin Pharma Recent Developments/Updates

6.11 LIVZON

6.11.1 LIVZON Corporation Information

6.11.2 LIVZON Proton Pump Inhibitors Description and Business Overview

6.11.3 LIVZON Proton Pump Inhibitors Sales, Revenue and Gross Margin (2019-2024)

6.11.4 LIVZON Proton Pump Inhibitors Product Portfolio

6.11.5 LIVZON Recent Developments/Updates

6.12 Eastchina Pharma

6.12.1 Eastchina Pharma Corporation Information

6.12.2 Eastchina Pharma Proton Pump Inhibitors Description and Business Overview

6.12.3 Eastchina Pharma Proton Pump Inhibitors Sales, Revenue and Gross Margin (2019-2024)

6.12.4 Eastchina Pharma Proton Pump Inhibitors Product Portfolio

6.12.5 Eastchina Pharma Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Proton Pump Inhibitors Industry Chain Analysis

7.2 Proton Pump Inhibitors Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Proton Pump Inhibitors Production Mode & Process

7.4 Proton Pump Inhibitors Sales and Marketing

7.4.1 Proton Pump Inhibitors Sales Channels

7.4.2 Proton Pump Inhibitors Distributors

7.5 Proton Pump Inhibitors Customers

8 Proton Pump Inhibitors Market Dynamics

8.1 Proton Pump Inhibitors Industry Trends

8.2 Proton Pump Inhibitors Market Drivers

8.3 Proton Pump Inhibitors Market Challenges

8.4 Proton Pump Inhibitors Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Proton Pump Inhibitors Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Proton Pump Inhibitors Market Value Comparison by Distribution Channel (2024-2030) & (US$ Million)

Table 3. Global Proton Pump Inhibitors Market Competitive Situation by Manufacturers in 2023

Table 4. Global Proton Pump Inhibitors Sales (M Units) of Key Manufacturers (2019-2024)

Table 5. Global Proton Pump Inhibitors Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Proton Pump Inhibitors Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Proton Pump Inhibitors Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Proton Pump Inhibitors Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Proton Pump Inhibitors, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Proton Pump Inhibitors, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Proton Pump Inhibitors, Product Type & Application

Table 12. Global Key Manufacturers of Proton Pump Inhibitors, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Proton Pump Inhibitors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Proton Pump Inhibitors as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Proton Pump Inhibitors Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Proton Pump Inhibitors Sales by Region (2019-2024) & (M Units)

Table 18. Global Proton Pump Inhibitors Sales Market Share by Region (2019-2024)

Table 19. Global Proton Pump Inhibitors Sales by Region (2025-2030) & (M Units)

Table 20. Global Proton Pump Inhibitors Sales Market Share by Region (2025-2030)

Table 21. Global Proton Pump Inhibitors Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Proton Pump Inhibitors Revenue Market Share by Region (2019-2024)

Table 23. Global Proton Pump Inhibitors Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Proton Pump Inhibitors Revenue Market Share by Region (2025-2030)

Table 25. North America Proton Pump Inhibitors Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Proton Pump Inhibitors Sales by Country (2019-2024) & (M Units)

Table 27. North America Proton Pump Inhibitors Sales by Country (2025-2030) & (M Units)

Table 28. North America Proton Pump Inhibitors Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Proton Pump Inhibitors Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Proton Pump Inhibitors Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Proton Pump Inhibitors Sales by Country (2019-2024) & (M Units)

Table 32. Europe Proton Pump Inhibitors Sales by Country (2025-2030) & (M Units)

Table 33. Europe Proton Pump Inhibitors Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Proton Pump Inhibitors Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Proton Pump Inhibitors Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Proton Pump Inhibitors Sales by Region (2019-2024) & (M Units)

Table 37. Asia Pacific Proton Pump Inhibitors Sales by Region (2025-2030) & (M Units)

Table 38. Asia Pacific Proton Pump Inhibitors Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Proton Pump Inhibitors Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Proton Pump Inhibitors Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Proton Pump Inhibitors Sales by Country (2019-2024) & (M Units)

Table 42. Latin America Proton Pump Inhibitors Sales by Country (2025-2030) & (M Units)

Table 43. Latin America Proton Pump Inhibitors Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Proton Pump Inhibitors Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Proton Pump Inhibitors Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Proton Pump Inhibitors Sales by Country (2019-2024) & (M Units)

Table 47. Middle East & Africa Proton Pump Inhibitors Sales by Country (2025-2030) & (M Units)

Table 48. Middle East & Africa Proton Pump Inhibitors Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Proton Pump Inhibitors Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Proton Pump Inhibitors Sales (M Units) by Type (2019-2024)

Table 51. Global Proton Pump Inhibitors Sales (M Units) by Type (2025-2030)

Table 52. Global Proton Pump Inhibitors Sales Market Share by Type (2019-2024)

Table 53. Global Proton Pump Inhibitors Sales Market Share by Type (2025-2030)

Table 54. Global Proton Pump Inhibitors Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Proton Pump Inhibitors Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Proton Pump Inhibitors Revenue Market Share by Type (2019-2024)

Table 57. Global Proton Pump Inhibitors Revenue Market Share by Type (2025-2030)

Table 58. Global Proton Pump Inhibitors Price (US$/Unit) by Type (2019-2024)

Table 59. Global Proton Pump Inhibitors Price (US$/Unit) by Type (2025-2030)

Table 60. Global Proton Pump Inhibitors Sales (M Units) by Distribution Channel (2019-2024)

Table 61. Global Proton Pump Inhibitors Sales (M Units) by Distribution Channel (2025-2030)

Table 62. Global Proton Pump Inhibitors Sales Market Share by Distribution Channel (2019-2024)

Table 63. Global Proton Pump Inhibitors Sales Market Share by Distribution Channel (2025-2030)

Table 64. Global Proton Pump Inhibitors Revenue (US$ Million) by Distribution Channel (2019-2024)

Table 65. Global Proton Pump Inhibitors Revenue (US$ Million) by Distribution Channel (2025-2030)

Table 66. Global Proton Pump Inhibitors Revenue Market Share by Distribution Channel (2019-2024)

Table 67. Global Proton Pump Inhibitors Revenue Market Share by Distribution Channel (2025-2030)

Table 68. Global Proton Pump Inhibitors Price (US$/Unit) by Distribution Channel (2019-2024)

Table 69. Global Proton Pump Inhibitors Price (US$/Unit) by Distribution Channel (2025-2030)

Table 70. Takeda Corporation Information

Table 71. Takeda Description and Business Overview

Table 72. Takeda Proton Pump Inhibitors Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. Takeda Proton Pump Inhibitors Product

Table 74. Takeda Recent Developments/Updates

Table 75. Pfizer Corporation Information

Table 76. Pfizer Description and Business Overview

Table 77. Pfizer Proton Pump Inhibitors Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. Pfizer Proton Pump Inhibitors Product

Table 79. Pfizer Recent Developments/Updates

Table 80. AstraZeneca Corporation Information

Table 81. AstraZeneca Description and Business Overview

Table 82. AstraZeneca Proton Pump Inhibitors Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. AstraZeneca Proton Pump Inhibitors Product

Table 84. AstraZeneca Recent Developments/Updates

Table 85. Bayer Corporation Information

Table 86. Bayer Description and Business Overview

Table 87. Bayer Proton Pump Inhibitors Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. Bayer Proton Pump Inhibitors Product

Table 89. Bayer Recent Developments/Updates

Table 90. Sun Pharma Corporation Information

Table 91. Sun Pharma Description and Business Overview

Table 92. Sun Pharma Proton Pump Inhibitors Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 93. Sun Pharma Proton Pump Inhibitors Product

Table 94. Sun Pharma Recent Developments/Updates

Table 95. Teva Corporation Information

Table 96. Teva Description and Business Overview

Table 97. Teva Proton Pump Inhibitors Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 98. Teva Proton Pump Inhibitors Product

Table 99. Teva Recent Developments/Updates

Table 100. Eisai Co. Corporation Information

Table 101. Eisai Co. Description and Business Overview

Table 102. Eisai Co. Proton Pump Inhibitors Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 103. Eisai Co. Proton Pump Inhibitors Product

Table 104. Eisai Co. Recent Developments/Updates

Table 105. Mylan Corporation Information

Table 106. Mylan Description and Business Overview

Table 107. Mylan Proton Pump Inhibitors Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 108. Mylan Proton Pump Inhibitors Product

Table 109. Mylan Recent Developments/Updates

Table 110. AOSAIKANG Pharma Corporation Information

Table 111. AOSAIKANG Pharma Description and Business Overview

Table 112. AOSAIKANG Pharma Proton Pump Inhibitors Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 113. AOSAIKANG Pharma Proton Pump Inhibitors Product

Table 114. AOSAIKANG Pharma Recent Developments/Updates

Table 115. Luoxin Pharma Corporation Information

Table 116. Luoxin Pharma Description and Business Overview

Table 117. Luoxin Pharma Proton Pump Inhibitors Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 118. Luoxin Pharma Proton Pump Inhibitors Product

Table 119. Luoxin Pharma Recent Developments/Updates

Table 120. LIVZON Corporation Information

Table 121. LIVZON Description and Business Overview

Table 122. LIVZON Proton Pump Inhibitors Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 123. LIVZON Proton Pump Inhibitors Product

Table 124. LIVZON Recent Developments/Updates

Table 125. Eastchina Pharma Corporation Information

Table 126. Eastchina Pharma Description and Business Overview

Table 127. Eastchina Pharma Proton Pump Inhibitors Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 128. Eastchina Pharma Proton Pump Inhibitors Product

Table 129. Eastchina Pharma Recent Developments/Updates

Table 130. Key Raw Materials Lists

Table 131. Raw Materials Key Suppliers Lists

Table 132. Proton Pump Inhibitors Distributors List

Table 133. Proton Pump Inhibitors Customers List

Table 134. Proton Pump Inhibitors Market Trends

Table 135. Proton Pump Inhibitors Market Drivers

Table 136. Proton Pump Inhibitors Market Challenges

Table 137. Proton Pump Inhibitors Market Restraints

Table 138. Research Programs/Design for This Report

Table 139. Key Data Information from Secondary Sources

Table 140. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Proton Pump Inhibitors

Figure 2. Global Proton Pump Inhibitors Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Proton Pump Inhibitors Market Share by Type in 2023 & 2030

Figure 4. Dexlansoprazole Product Picture

Figure 5. Esomeprazole Product Picture

Figure 6. Lansoprazole Product Picture

Figure 7. Omeprazole Product Picture

Figure 8. Pantoprazole Product Picture

Figure 9. Rabeprazole Product Picture

Figure 10. Global Proton Pump Inhibitors Market Value Comparison by Distribution Channel (2024-2030) & (US$ Million)

Figure 11. Global Proton Pump Inhibitors Market Share by Distribution Channel in 2023 & 2030

Figure 12. Hospital Pharmacy

Figure 13. Retail Pharmacy

Figure 14. Others

Figure 15. Global Proton Pump Inhibitors Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global Proton Pump Inhibitors Market Size (2019-2030) & (US$ Million)

Figure 17. Global Proton Pump Inhibitors Sales (2019-2030) & (M Units)

Figure 18. Global Proton Pump Inhibitors Average Price (US$/Unit) & (2019-2030)

Figure 19. Proton Pump Inhibitors Report Years Considered

Figure 20. Proton Pump Inhibitors Sales Share by Manufacturers in 2023

Figure 21. Global Proton Pump Inhibitors Revenue Share by Manufacturers in 2023

Figure 22. The Global 5 and 10 Largest Proton Pump Inhibitors Players: Market Share by Revenue in 2023

Figure 23. Proton Pump Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 24. Global Proton Pump Inhibitors Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 25. North America Proton Pump Inhibitors Sales Market Share by Country (2019-2030)

Figure 26. North America Proton Pump Inhibitors Revenue Market Share by Country (2019-2030)

Figure 27. United States Proton Pump Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. Canada Proton Pump Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. Europe Proton Pump Inhibitors Sales Market Share by Country (2019-2030)

Figure 30. Europe Proton Pump Inhibitors Revenue Market Share by Country (2019-2030)

Figure 31. Germany Proton Pump Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. France Proton Pump Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. U.K. Proton Pump Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. Italy Proton Pump Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. Russia Proton Pump Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. Asia Pacific Proton Pump Inhibitors Sales Market Share by Region (2019-2030)

Figure 37. Asia Pacific Proton Pump Inhibitors Revenue Market Share by Region (2019-2030)

Figure 38. China Proton Pump Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Japan Proton Pump Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. South Korea Proton Pump Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. India Proton Pump Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Australia Proton Pump Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. China Taiwan Proton Pump Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Indonesia Proton Pump Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Thailand Proton Pump Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Malaysia Proton Pump Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Latin America Proton Pump Inhibitors Sales Market Share by Country (2019-2030)

Figure 48. Latin America Proton Pump Inhibitors Revenue Market Share by Country (2019-2030)

Figure 49. Mexico Proton Pump Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Brazil Proton Pump Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Argentina Proton Pump Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. Middle East & Africa Proton Pump Inhibitors Sales Market Share by Country (2019-2030)

Figure 53. Middle East & Africa Proton Pump Inhibitors Revenue Market Share by Country (2019-2030)

Figure 54. Turkey Proton Pump Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 55. Saudi Arabia Proton Pump Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 56. UAE Proton Pump Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 57. Global Sales Market Share of Proton Pump Inhibitors by Type (2019-2030)

Figure 58. Global Revenue Market Share of Proton Pump Inhibitors by Type (2019-2030)

Figure 59. Global Proton Pump Inhibitors Price (US$/Unit) by Type (2019-2030)

Figure 60. Global Sales Market Share of Proton Pump Inhibitors by Distribution Channel (2019-2030)

Figure 61. Global Revenue Market Share of Proton Pump Inhibitors by Distribution Channel (2019-2030)

Figure 62. Global Proton Pump Inhibitors Price (US$/Unit) by Distribution Channel (2019-2030)

Figure 63. Proton Pump Inhibitors Value Chain

Figure 64. Proton Pump Inhibitors Production Process

Figure 65. Channels of Distribution (Direct Vs Distribution)

Figure 66. Distributors Profiles

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions